A New Regulatory Environment for Transfer Pricing in France? Recent Developments and their Implications for Taxpayers
Paris, France
16 January 2009
Hosted By: the Institut de Formation des Industries de Santé (IFIS)
Tax and legal experts convened at this conference, hosted by the Institut de Formation des Industries de Santé in Paris on 16 January 2009, to discuss tax and legal risks and related opportunities facing companies in the pharmaceutical industry. As part of the conference, NERA Associate Director Jean-Sébastien Lénik delivered a presentation examining the likely developments of the transfer pricing regulatory framework in France and their implications for taxpayers, with a focus on pharmaceutical players.
To contact us about this event, please click here.
